Patents by Inventor Agnès Hincelin-Mery

Agnès Hincelin-Mery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING RECEPTOR-INTERACTING PROTEIN KINASE 1-MEDIATED DISEASES
    Publication number: 20240100065
    Abstract: This disclosure relates to the field of therapeutic tyrosine kinase inhibitors, in particular receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors, to treat a receptor-interacting protein kinase 1-mediated disease or disorder.
    Type: Application
    Filed: August 22, 2023
    Publication date: March 28, 2024
    Applicant: Genzyme Corporation
    Inventors: Nazem Atassi, Catherine Cantalloube, Agnès Hincelin-Mery, Donato Teutonico
  • TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS
    Publication number: 20210187075
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: September 22, 2020
    Publication date: June 24, 2021
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS
    Publication number: 20190365864
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: February 4, 2019
    Publication date: December 5, 2019
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • Treatment of Pediatric Type 2 Diabetes Mellitus Patients
    Publication number: 20160235818
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: January 14, 2016
    Publication date: August 18, 2016
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES TYPE 2 PATIENTS
    Publication number: 20130065828
    Abstract: The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
    Type: Application
    Filed: May 11, 2012
    Publication date: March 14, 2013
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Peter RUUS, Louise SILVESTRE, Patrick MIOSSEC, Jean-Louis PINQUIER, Agnes HINCELIN-MERY